Late Recurrence of Breast Cancer Nearly 30 Years After Surgery: Mediastinal and Hilar Lymph Node Metastases Diagnosed Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
Authors:
Open Access
- 20 November 2025
- journal article
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Abstract
Late recurrence of breast cancer occurring more than two decades after curative surgery is rare, but in the era of prolonged survival, clinicians may increasingly encounter such cases. Mediastinal or hilar recurrence may radiologically mimic primary lung cancer; however, histological confirmation using endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) enables accurate diagnosis with minimal invasiveness. We report the cases of two patients who developed mediastinal and hilar lymph node metastases nearly 30 years after breast cancer surgery, for whom EBUS-TBNA played a crucial diagnostic role. A 68-year-old woman with a history of right mastectomy for stage I (T1aN0M0) breast cancer 30 years earlier presented with cough and hemoptysis. Chest computed tomography revealed multiple pulmonary nodules, right hilar lymphadenopathy, and sclerotic bone lesions. Fluorodeoxyglucose positron emission tomography/computed tomography showed intense uptake in the right hilar lymph nodes and bones, whereas pulmonary nodules demonstrated only mild uptake. EBUS-TBNA of station 12R revealed adenocarcinoma positive for estrogen and progesterone receptors and negative for human epidermal growth factor receptor 2, confirming metastatic breast carcinoma. The patient was treated with abemaciclib plus fulvestrant, achieving durable disease control for 2.5 years. A 70-year-old woman who had undergone left mastectomy 27 years earlier presented with a dry cough. EBUS-TBNA of stations 4R and 7 confirmed metastatic breast carcinoma. She received nab-paclitaxel followed by trastuzumab deruxtecan, achieving disease control for 20 months. These cases demonstrate that even very late recurrences nearly three decades after surgery can achieve prolonged survival when appropriately diagnosed and optimally treated. EBUS-TBNA is a valuable and minimally invasive diagnostic tool for confirming such a late recurrence.Keywords
This publication has 18 references indexed in Scilit:
- The Incidence of Breast Cancer Recurrence 10-32 Years After Primary DiagnosisJNCI: Journal of the National Cancer Institute, 2021
- Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateJournal of Clinical Oncology, 2020
- Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in the Diagnosis of Breast Cancer Thoracic Metastases and Detection of Receptor DiscordanceJournal of Bronchology & Interventional Pulmonology, 2018
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 YearsNew England Journal of Medicine, 2017
- Endobronchial Ultrasound–guided Transbronchial Needle Aspiration Prevents Mediastinoscopies in the Diagnosis of Isolated Mediastinal Lymphadenopathy: A Prospective TrialAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working GroupJNCI: Journal of the National Cancer Institute, 2011
- Does tumour dormancy offer a therapeutic target?Nature Reviews Cancer, 2010
- Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant TherapyJNCI: Journal of the National Cancer Institute, 2008
- Metastatic patterns in adenocarcinomaCancer, 2006
- Breast CancerNew England Journal of Medicine, 1992